SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.35-0.8%Dec 2 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Torben Noerup Nielsen who wrote (15600)2/22/1998 12:01:00 PM
From: Hippieslayer  Read Replies (2) of 32384
 
Torben,

Very well thought out response.
Looks like little bobbie needs to brush up on his annual report reading. Sorry Bob, looks like the tables have turned where someone has to correct you.:-)

As much as he might want LGND to become a powerhouse Pharma like LLY, I think LGND's niche will most likely be two pronged. One: in house development and testing of certain molecules that ligand finds most promising to fulfill their own goals. And 2) seeding out other promising molecules to Big Pharmas for collaborative agreements.
Whether or not this is correct will only be discovered once Ligand has a couple drugs out on the market-which means possibly another year or two.

Again, thank you for putting a more appropriate focus on where Ligand is most likely headed.

Fugazi Ligand.

PS, be careful of people who try to use the price of one company's stock to justify the theoretical and future value of another corps stock price. It's pure conjecture that has no basis for discussion.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News